Table 1.
Demographic and laboratory results.
Fig 1.
Changes in fecal bile acid composition in HC, NAFL and NASH patients.
Fig 2.
Correlations with fecal unconjugated primary bile acids.
(A) Correlation of fecal unconjugated primary bile acids and NAS (p < 0.001, r = 0.528). (B) Correlation of fecal unconjugated primary bile acids and plasma ALT (p < 0.001, r = 0.531). (C) Correlation of fecal unconjugated primary bile acids and serum triglycerides (p = 0.021, r = 0.338).
Table 2.
Unconjugated fecal bile acid composition and comparisons between the groups (n = 53).
Table 3.
Conjugated primary and secondary bile acid distribution in the study population (n = 53).
Fig 3.
Serum C4 and FGF19 levels in HC, NAFL and NASH groups.
(A) Serum C4 levels in HC, NAFL and NASH (n = 48) *p < 0.05 compared to HC. (B) Serum fibroblast growth factor 19 (FGF19) levels in HC, NAFL and NASH (n = 46).
Table 4.
Serum C4 in the study population (n = 48).
Table 5.
Serum FGF19 in the study population (n = 46).